These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30170163)

  • 21. MDMA-induced angioedema treated with icatibant.
    Escalante FA; Del Baño F; Supervía A
    Clin Toxicol (Phila); 2015; 53(10):1148-9. PubMed ID: 26479353
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
    Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
    J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist.
    Pucar PA; O'Sullivan M; Goudie A; Marr T; Brusch A
    Med J Aust; 2015 Jun; 202(11):596-7. PubMed ID: 26068694
    [No Abstract]   [Full Text] [Related]  

  • 24. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
    Baş M; Greve J; Hoffmann TK; Reshef A; Aberer W; Maurer M; Kivity S; Farkas H; Floccard B; Arcoleo F; Martin L; Sitkauskiene B; Bouillet L; Schmid-Grendelmeier P; Li H; Zanichelli A
    Allergy; 2013 Nov; 68(11):1452-9. PubMed ID: 24111645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries.
    Toubi E; Kivity S; Graif Y; Reshef A; Botha J; Andresen I
    Isr Med Assoc J; 2018 Apr; 20(4):227-232. PubMed ID: 29629730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and emerging therapies to prevent hereditary angioedema attacks.
    Lumry WR
    Am J Manag Care; 2018 Aug; 24(14 Suppl):S299-S307. PubMed ID: 30132644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Icatibant for hereditary angioedema.
    Gras J
    Drugs Today (Barc); 2009 Dec; 45(12):855-64. PubMed ID: 20135020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.
    Farkas H; Kőhalmi KV
    Expert Rev Clin Immunol; 2018 Jun; 14(6):447-460. PubMed ID: 29757016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of icatibant (HOE-140, JE-049).
    Cruden NL; Newby DE
    Expert Opin Pharmacother; 2008 Sep; 9(13):2383-90. PubMed ID: 18710362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Icatibant.
    Dubois EA; Cohen AF
    Br J Clin Pharmacol; 2010 May; 69(5):425-6. PubMed ID: 20573077
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED.
    Bartal C; Zeldetz V; Stavi V; Barski L
    Am J Emerg Med; 2015 Mar; 33(3):479.e1-3. PubMed ID: 25241359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].
    Muller Y; Harr T
    Rev Med Suisse; 2016 Jan; 12(500):11-2. PubMed ID: 26946694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema.
    Farkas H; Reshef A; Caballero T; Ortega López MC; Kessel A; Vardi M; Hao J; Aberer W
    Pediatr Allergy Immunol; 2021 Aug; 32(6):1392-1396. PubMed ID: 33851451
    [No Abstract]   [Full Text] [Related]  

  • 35. Real-life experience with long-term prophylactic C1 inhibitor concentrate treatment of patients with hereditary angioedema: Effectiveness and cost.
    Rasmussen ER; Aagaard L; Bygum A
    Ann Allergy Asthma Immunol; 2016 May; 116(5):476-7. PubMed ID: 27017563
    [No Abstract]   [Full Text] [Related]  

  • 36. Icatibant.
    Deeks ED
    Drugs; 2010; 70(1):73-81. PubMed ID: 20030426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful perioperative management of a patient with C1 esterase inhibitor deficiency with a novel bradykinin receptor B2 antagonist.
    Senaratne KT; Cottrell AM; Prentice RI
    Anaesth Intensive Care; 2012 May; 40(3):523-6. PubMed ID: 22577920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
    Fok JS; Katelaris CH; Brown AF; Smith WB
    Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary angioedema--therapies old and new.
    Morgan BP
    N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
    [No Abstract]   [Full Text] [Related]  

  • 40. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
    Piras V; Alves F; Gonçalo M
    Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.